Specialized Therapeutic Solutions for Cholestatic Diseases in Unique Operational Environments

Publication ID: 24-11857523_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Therapeutic Solutions for Cholestatic Diseases in Unique Operational Environments,” Published Technical Disclosure No. 24-11857523_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857523_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,523.

Summary of the Inventive Concept

The inventive concept adapts the original method of treating cholestatic diseases for specific, narrow markets or unique operational environments, providing targeted therapeutic solutions for high-altitude, disaster relief, high-security, and extreme weather settings.

Background and Problem Solved

The original patent addresses the treatment of cholestatic diseases, primarily PBC and PSC. However, the original method may not be effective or practical in unique operational environments, such as high-altitude, disaster relief, high-security, or extreme weather settings, where subjects may have compromised respiratory, immune, or other systems. The new inventive concept solves this problem by providing specialized therapeutic solutions tailored to these specific environments.

Detailed Description of the Inventive Concept

The inventive concept comprises a set of specialized methods and systems for treating cholestatic diseases in unique operational environments. In a high-altitude environment, the method administers a therapeutically effective amount of a composition comprising elafibranor to a subject with a compromised respiratory system. In a disaster relief setting, the system includes a portable device for administering elafibranor and a power source operable in a low-infrastructure environment. For subjects with compromised immune systems, the method combines elafibranor with an immunomodulator. In high-security environments, the system features a secure storage unit for elafibranor and a biometric authentication device for authorized access. For subjects with a history of extreme weather exposure, the method incorporates an antioxidant with elafibranor.

Novelty and Inventive Step

The new claims introduce novel and non-obvious adaptations of the original method to address the specific challenges of unique operational environments. The inventive concept's novelty lies in its tailored approach to treating cholestatic diseases in these environments, which is not addressed by the original patent.

Alternative Embodiments and Variations

Alternative embodiments may include variations of the composition, dosage, or administration route, as well as modifications to the portable device, power source, secure storage unit, or biometric authentication device. Additionally, the inventive concept could be adapted for other unique operational environments, such as space exploration or remote wilderness areas.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical and medical device industries, particularly in niche markets catering to high-altitude, disaster relief, high-security, and extreme weather environments. Target industries may include military, aerospace, emergency response, and specialized healthcare providers.

CPC Classifications

SectionClassGroup
A A61 A61K31/192
A A61 A61K45/06
A A61 A61P37/06

Original Patent Information

Patent NumberUS 11,857,523
TitleMethods of treatment of cholestatic diseases
Assignee(s)Genfit